These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 80785)

  • 1. [Estrogen-resistant prostatic cancer with bone metastases: palliative chemotherapy with 5-fluorouracil and cyclophosphamide].
    Küss R; Khoury S; Richard F; Fourcade R; Frantz P; Capelle JP
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2478-9. PubMed ID: 80785
    [No Abstract]   [Full Text] [Related]  

  • 2. [Palliative chemotherapy with 5 FU and CPM in cancer of the prostate with bone metastases resistant to oestrogens. A clinical trial (author's transl)].
    Kuss R; Khoury S; Richard F; Fourcade R; Frantz P; Capelle JP
    J Urol Nephrol (Paris); 1979; 85(10-11):649-55. PubMed ID: 94108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trial of combined intermittent chemotherapy in prostatic cancers. Estrogen resistant metastases].
    Chauvin HF
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):397-8. PubMed ID: 4807868
    [No Abstract]   [Full Text] [Related]  

  • 4. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
    Eagan RT; Hahn RG; Myers RP
    Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytostatic therapy of prostatic carcinoma. Current status and personal results].
    Nagel R; Leistenschneider W
    Urologe A; 1983 Sep; 22 Suppl():304-9. PubMed ID: 6356555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination cytostatic chemotherapy of advanced metastatic cancer of the prostate. A preliminary uncontrolled study].
    Ogaard S; Jensen TS
    Ugeskr Laeger; 1977 Feb; 139(9):515-7. PubMed ID: 841743
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vascular accidents of estrogen therapy for prostatic cancer metastases].
    Jurascheck F
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):400-2. PubMed ID: 4804405
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
    Mannes P; Derriks R
    Acta Tuberc Pneumol Belg; 1968; 59(2):445-54. PubMed ID: 5720490
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer].
    Köller A; Lunglmayr G
    Wien Med Wochenschr; 1983; 133(7):179-81. PubMed ID: 6868629
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trepanobiopsy of the iliac bone in the diagnosis of bone metastasis of prostate carcinoma and in control of the efficacy of estrogen therapy].
    Mazin VV; Komarova LI; Mazina NM
    Urol Nefrol (Mosk); 1977; (3):41-2. PubMed ID: 878087
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in 87mSr concentractions in skeletal metastases in patients responding to cyclical combination chemotherapy for advanced breast cancer.
    Gillespie PJ; Alexander JL; Edelstyn GA
    J Nucl Med; 1975 Mar; 16(3):191-3. PubMed ID: 1113166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
    Schmidt JD; Scott WW; Gibbons R; Johnson DE; Prout GR; Loening S; Soloway M; deKernion JB; Pontes JE; Slack NH; Murphy GP
    Cancer; 1980 Apr; 45(7 Suppl):1937-46. PubMed ID: 6445225
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone and chemotherapy of breast carcinoma].
    Rotte K; Caffier H
    Med Klin; 1977 Aug; 72(31):1263-9. PubMed ID: 331054
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
    Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of advanced prostatic cancer today.
    Murphy GP; Merrin CE
    Prog Clin Biol Res; 1976; 6():285-99. PubMed ID: 139614
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of skeletal metastases.
    Cadman E; Bertino JR
    Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1211-5. PubMed ID: 62744
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclophosphamide-prednisolone therapy in advanced prostatic carcinoma.
    Andersson L; Edsmyr F; Esposti PL; Hedlund PO; Rönström L
    Scand J Urol Nephrol Suppl; 1980; 55():169-71. PubMed ID: 6938021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful relief of severe pain from bone metastases of carcinoma of the prostate by the treatment with P32].
    Nakaarai K; Tokizane M; Okuda N; Ito S
    Hinyokika Kiyo; 1966 Dec; 12(12):1429-34. PubMed ID: 4167082
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advanced cancer of the prostate: chemotherapy].
    Garcia-Giralt E; Palangie T; Dorval T; Jouve M; Pouillart P
    Bull Cancer; 1986; 73(1):68-73. PubMed ID: 3779125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.